Nuzenio

Stock Titan Spyre

Stock Titan Spyre entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 6 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Fri, 07 Aug 2026 20:40:02 GMTSpyre Therapeutics, Inc. SEC Filing (Aug 7, 2026) - Stock Titan

Thu, 06 Aug 2026 02:18:24 GMTSpyre Therapeutics (SYRE) CFO sells 7,500 shares after option exercise - Stock Titan

Thu, 06 Aug 2026 02:18:24 GMTSpyre Therapeutics (SYRE) CEO trades 15,000 shares under 10b5-1 plan - Stock Titan

Tue, 04 Aug 2026 20:03:23 GMTSpyre Therapeutics (Nasdaq: SYRE) holds $1.1B cash despite higher 2026 loss - Stock Titan

Tue, 04 Aug 2026 20:02:00 GMTSpyre expects six Phase 2 trial readouts in 2026; cash totals $1.1B - Stock Titan

Mon, 03 Aug 2026 20:52:09 GMTSYRE (NASDAQ: SYRE) insider schedules 30,000-share stock sale notice - Stock Titan

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Spyre.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

1 distinct publisher/source names are currently connected to this entity page.